Avior Wealth Management’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Avior Wealth Management’s Portfolio MBII Stock Details MBII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-10,000	Closed	-$11K	–	1342
2022 Q2	$11K	Hold	10,000	–	–	﹤0.01%	765
2022 Q1	$10K	Hold	10,000	–	–	﹤0.01%	835
2021 Q4	$7K	Hold	10,000	–	–	﹤0.01%	853
2021 Q3	$9K	Hold	10,000	–	–	﹤0.01%	786
2021 Q2	$16K	Hold	10,000	–	–	﹤0.01%	681
2021 Q1	$20K	Hold	10,000	–	–	﹤0.01%	653
2020 Q4	$12K	Hold	10,000	–	–	﹤0.01%	691
2020 Q3	$12K	Hold	10,000	–	–	﹤0.01%	669
2020 Q2	$11K	Buy	+10,000	New	+$9.25K	﹤0.01%	661

Avior Wealth Management's MBII Position: Q3 2022 in Review

Avior Wealth Management sold out of Marrone Bio Innovations, Inc. (MBII) in Q3 2022, closing a stake of 10,000 shares — an estimated $11K sold.

Avior Wealth Management first reported a position in MBII in Q2 2020 and held it in 9 quarters. The position peaked at $20K in Q1 2021. 0 funds tracked by Wall St. Rank hold MBII as of Q3 2022.

Avior Wealth Management reported no remaining Marrone Bio Innovations, Inc. position as of Q3 2022 after selling out during the quarter.
Avior Wealth Management sold 10,000 Marrone Bio Innovations, Inc. shares in Q3 2022, an estimated $11K.
Avior Wealth Management first reported a position in Marrone Bio Innovations, Inc. in Q2 2020 and held it in 9 quarters.
Avior Wealth Management's Marrone Bio Innovations, Inc. position peaked at $20K in Q1 2021.
0 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q3 2022.

Based on Avior Wealth Management's 13F filing for Q3 2022, filed 26 Oct 2022.